<div id="readability-page-1">03:41 PM EST, 12/04/2025 (MT Newswires) -- Humana (HUM) is working with entrepreneur Mark Cuban on a potential pharmacy partnership through Cuban's Cost Plus Drugs venture, Bloomberg reported Thursday, citing comments made by Humana's chief executive officer Jim Rechtin at a Forbes healthcare conference.Cuban said the discussions include direct-to-employer programs aimed at bypassing traditional drug-supply-chain layers, the report said. Rechtin said the goal is to simplify how medications move from manufacturers to patients, the report said.Humana and Cost Plus Drugs did not immediately respond to MT Newswires' request for comment on the matter.Shares of Humana were down 2.14% in recent Thursday trading.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: 251.99, Change: -4.93, Percent Change: -1.92 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

休曼納

休曼納正在與馬克·庫班的 Cost Plus Drugs 探索藥房合作，旨在簡化藥物分發。討論內容包括直接面向僱主的項目，以繞過傳統的藥物供應鏈層級。休曼納的股價在消息公佈後下跌了 2.14%

市場傳聞：休曼納正在考慮與馬克·庫班進行藥房合作